Bayer AG Hunts For More Deals After Bulking Up Consumer Care

October 30, 2014

By Riley McDermid, BioSpace.com Breaking News Staff

German drugmaker Bayer is going hunting for deals again, with its chief executive expected to tell media outlets on Thursday that it is looking for further takeover deals.

"We are looking to expand our business in the future through both organic growth and acquisitions," CEO Marijn Dekkers is slated to say in a speech to during the company’s third quarter results reporting on Thursday. News outlets received a copy of the speech ahead of time.

Bayer snapped up Merck & Co. Inc. 's consumer health business earlier this year for $14.2 billion.

“This acquisition marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business," said Dekkers at the time. “At the same time we are leveraging our capabilities in the cardiovascular therapeutic area.”